<DOC>
	<DOCNO>NCT01689363</DOCNO>
	<brief_summary>This study design evaluate allergenicity AmphadaseÂ® healthy volunteer use intradermal skin test .</brief_summary>
	<brief_title>Evaluation Allergenicity AMPHADASE INJECTION ( Hyaluronidase Injection USP )</brief_title>
	<detailed_description />
	<mesh_term>Histamine</mesh_term>
	<mesh_term>Histamine phosphate</mesh_term>
	<criteria>Healthy volunteer either gender ; Those without clinically significant cardiovascular gastrointestinal , hepatic , neurological , psychiatric , endocrine , major systemic disease would unduly risk subject 's safety interfere interpretation result , assess accord judgment Principal Investigator . A noninclusive list would exclusionary define healthy individual purpose study : hypothyroidism , stable hypertension except subject beta blocker include ocular preparation , seasonal/perennial allergic rhinitis able wash antihistamine , stable , mild intermittent asthma ( subject use beta agonist monotherapy asneeded basis , exclude daily usage ) , migraine take excluded medication , mild anxiety/depression take excluded medication , mild arthritic condition take excluded medication . Willingness ability sign inform consent document ; 18 80 year age ; Intact skin forearm ; Female participant currently practice effective birth control method abstinence . Known allergy , hypersensitivity contraindication hyaluronidase , thimerosal , edetate disodium ( EDTA ) ; Use medication within duration consider interfere skin testing . Known dermographism may interfere skin test . Pregnant lactating woman .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>hyaluronidase</keyword>
	<keyword>enzyme tissue spread activity</keyword>
	<keyword>allergic reaction</keyword>
	<keyword>intradermal skin test</keyword>
</DOC>